This brand name is authorized in Austria, Australia, Cyprus, Germany, Estonia, Spain, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Mexico, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa
The drug SOLIAN contains one active pharmaceutical ingredient (API):
|
1
Amisulpride
UNII 8110R61I4U - AMISULPRIDE
|
|
Amisulpride is a neuroleptic. Amisulpride binds selectively with a high affinity to human dopaminergic D2/D3 receptor subtypes whereas it is devoid of affinity for D1, D4 and D5 receptor subtypes. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| SOLIAN Tablets | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N05AL05 | Amisulpride | N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AL Benzamides |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 8594H, 8595J, 8596K, 8736T |
| Country: DE | Bundesinstitut für Arzneimittel und Medizinprodukte | Identifier(s): 00018431, 01827397, 01827434, 01827440, 02246917, 06136433, 08425012, 08425029 |
| Country: EE | Ravimiamet | Identifier(s): 1012105, 1041141, 1067497 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 5267, 63994, 63995, 63996, 65991 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 60019927, 62921036, 63697872, 64726693, 65637856 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 143684, 143691, 143697, 19246, 19247, 19250, 28422, 39342 |
| Country: HK | Department of Health Drug Office | Identifier(s): 46025, 47779, 47780 |
| Country: HR | Agencija za lijekove i medicinske proizvode | Identifier(s): HR-H-345193647 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 46655, 46708, 46724, 46857, 46870, 62895, 62897 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 4588, 4589 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 033462021, 033462045 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1003162, 1003618, 1012368, 1067873, 1087921 |
| Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 580M2000 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100098237, 100098243, 100098266, 100375010, 100450297, 100458238, 100461179 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W64419001, W64420001 |
| Country: SG | Health Sciences Authority | Identifier(s): 09773P, 11463P, 11464P |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 6483104, 6483105 |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699809018563, 8699809018570, 8699809097759, 8699809097766, 8699809655065 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 34/2.6.5/0116, 34/2.6.5/0117 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
